← Back to Search

Other

All Participants for Overmedication

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test a program to help ensure medication is correctly taken after leaving the hospital, improving patient health outcomes. #medicationoptimization

Who is the study for?

This trial is for adults aged 65 or older who have been hospitalized recently and are transitioning to home care with a referral from URMHC. Participants must be on more than 10 daily medications, have a primary care provider in the URMC system, can consent themselves, and speak English. Those in hospice or end-of-life care, with severe cognitive issues or communication disabilities that prevent effective participation are excluded.Check my eligibility

What is being tested?

The study is testing 'HomeMed,' a medication optimization program designed to improve health outcomes for seniors after they leave the hospital and return home. The goal is to see if this program helps reduce complications and prevents future hospital stays during this vulnerable transition period.See study design

What are the potential side effects?

Since HomeMed involves adjusting medications rather than administering new ones, side effects may include changes in how participants feel as their medication regimens are altered. This could potentially lead to withdrawal symptoms from reduced dosages or interactions due to changes in medication combinations.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Percentage of intervention adherence indicators checked

Percentage of participants undergoing deprescribing

Percentage of participants who report a reduction in medication side effect

+5 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: All ParticipantsExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

840 Previous Clinical Trials

534,245 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,880 Total Patients Enrolled

Media Library

HomeMed (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05630144 — N/A

Overmedication Research Study Groups: All Participants

Overmedication Clinical Trial 2023: HomeMed Highlights & Side Effects. Trial Name: NCT05630144 — N/A

HomeMed (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05630144 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment period for this experiment still ongoing?

"The details provided on clinicaltrials.gov denote that this medical experiment is not actively seeking participants at the moment, having been first posted in January and last updated late November of 2022. Nevertheless, 25 other trials are currently recruiting patients."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Deprescribing for Older Adults After Hospital Discharge in Home Health Care

Jinjiao Wang 2023. "Deprescribing for Older Adults After Hospital Discharge in Home Health Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05630144.